MDNews - Mid Penn

Innovations 2017

Issue link: http://viewer.e-digitaledition.com/i/884976

Contents of this Issue

Navigation

Page 10 of 19

MANY PATIENTS WITH COMPLE X REGIONAL PAIN SYNDROME AND PERIPHER AL CAUSALGIA FAIL TO ACHIE VE ADEQUATE PAIN CONTROL WITH CONVENTIONAL MEDICATION AND SPINAL CORD STIMUL ATION. NOW, THE NEUROSURGERY TE AM AT PENN STATE HE ALTH MILTON S. HERSHE Y MEDICAL CENTER OFFERS A NE W PROCEDURE AS A MORE EFFECTIVE ALTERNATIVE ¢ THE RECENTLY FDAŸAPPROVED DORSAL ROOT GANGLION STIMUL ATION THER APY. A LTHOUGH THE E X ACT ORIGINS of complex regional pain syndrome are unknown, in more than 90 percent of cases, an injury or trauma is believed to have triggered the condition; according to the National Institute of Neurological Disorders and Stroke, it is often the result of a broken bone, soft-tissue injuries or surgery. When complex regional pain syndrome stems from an injury to a specific nerve, the condition is known as complex regional pain syndrome II, or peripheral causalgia. An example of peripheral causalgia is damage to the ilioinguinal nerve following hernia repair, causing chronic burning or tingling in the groin at the site of the hernia, according to Michael Sather, MD, neurosurgeon at Hershey Medical Center. GREATER SUCCESS The defining feature of complex regional pa in sy ndrome is severe pa in out of proportion to a patient's original injury, according to the Genetic and Rare Diseases Information Center. In patients for whom medication does not control pain adequately, physicians may recommend either neuromodulation with spinal cord stimulation or dorsal root ganglion stimulation therapy. Dorsal root ganglion stimulation therapy di‡ers from spinal cord stimulation, because the therapy operates at the nerve level. It interrupts pain signals being transmitted from the periphery to the central nervous system by modulating the dorsal root ganglion, the site where pain signals from peripheral injuries originate. As a result, the treatment targets a specific nerve distribution and is more focused than spinal cord stimulation. "While both procedures o‡er significant pain relief, success rates are higher for those who receive the more focal dorsal root ganglion stimulation therapy," Dr. Sather says. "As an additional benefit, patients who have dorsal root ganglion stimulation therapy are less likely to experience paresthesia in areas outside the immediate treatment area than those who receive spinal cord stimulation." A TWO-PART PROCEDURE I n 2 016 , t he F DA a ppr ove d dor s a l root ganglion stimulation therapy for t reat ment of pa i n or i g i nat i n g f rom the nerves between T10 and S2, which includes pain in the abdomen, groin and bilateral lower extremities. Dr. Sather, t h e on l y n e u r o s u r ge on i n c e nt r a l Pennsylvania to currently perform dorsal root ganglion stimulation therapy, uses the A xium Neurostimulator System — the only system approved by the FDA for this purpose. P r i or t o i mpl a nt i n g t h e A x iu m Neurostimulator System generator, physicians establish patients into a trial period during which electrodes in the back are connected to an external generator to assess the amount of pain relief achieved by this method. If patients achieve 50 percent pain relief during the trial period, they are candidates for interna l implantation. Dr. Sather began o‡ering this procedure in early 2017. So far, he's treated patients with nerve damage following abdominal surgery and phantom limb pain, with high self-reported pain reduction rates of 100 and 90 percent, respectively. To refer a patient for evaluation, call 717-531-3828. ■ RESEARCH CONFIRMED EFFECTIVENESS A 2017 study published in PAIN found that of 152 patients with intractable lower-extremity pain, 81.2 percent achieved pain control at three months with dorsal root ganglion stimulation therapy, compared with 55.7 percent who received spinal cord stimulation. Improving Quality of Life for Patients with Intractable Pain BY TIFFANY PARNELL M D N E W S .C O M /// M D N E W S M I D P E N N ■ 2 017 P A I N M A N A G E M E N T 1 1

Articles in this issue

Archives of this issue

view archives of MDNews - Mid Penn - Innovations 2017